Systemic therapy of rosacea;Systemische Therapie der Rosazea

Hautarzt

Volumn 64, Issue 7, 2013, Pages 500-505

  Schaller, M ^a   Belge, K ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Demodicosis; Macrolides; Subtypes; Systemic therapy; Tetracycline

Indexed keywords

AZITHROMYCIN; CORTICOSTEROID; DAPSONE; DOXYCYCLINE; ISOTRETINOIN; MACROLIDE; METRONIDAZOLE; TETRACYCLINE DERIVATIVE;

ARTICLE; CORTICOSTEROID THERAPY; DEMODICOSIS; DIFFERENTIAL DIAGNOSIS; HUMAN; ROSACEA; SEBACEOUS GLAND HYPERPLASIA; SYSTEMIC THERAPY;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; DAPSONE; DERMATOLOGIC AGENTS; DOXYCYCLINE; HUMANS; INJECTIONS, INTRAVENOUS; ROSACEA; STEROIDS;

EID: 84887844816     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-012-2519-4     Document Type: Article

References (32)

1. Akhyani M, Ehsani AH, Ghiasi M, Jafari AK (2008) Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial. Int J Dermatol 47(3):284-288
2. Allen KJ, Davis CL, Billings SD, Mousdicas N (2007) Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin. Cutis 80(2):149-151
3. Alvarez-Elcoro S, Enzler MJ (1999) The macrolides: erythromycin, clarithromycin, and azithromycin. Mayo Clin Proc 74(6):613-634
4. Bakar O, Demircay Z, Toker E, Cakir S (2009) Ocular signs, symptoms and tearfunction tests of papulopustular rosacea patients receiving azithromycin. J Eur Acad Dermatol Venereol 23(5):544-549
5. Bormann G, Gaber G, Fischer M, Marsch WC (2001) Dapsone in rosacea fulminans. J Eur Acad Dermatol Venereol 15(5):465-467
6. Camous X, Calbo S, Picard D, Musette P (2012) Drug reaction with eosinophilia and systemic symptoms: an update on pathogenesis. Curr Opin Immunol 24(6):730-735
7. Coleman MD (1993) Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol 129(5):507-513
8. Craige H, Cohen JB (2005) Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol. J Am Acad Dermatol 53(5):881-884
9. Del Rosso JQ, Schlessinger J, Werschler P (2008) Comparison of anti-inflammatory dose doxy-cycline versus doxycycline 100 mg in the treatment of rosacea. J Drugs Dermatol 7(6):573-576
10. Erdogan FG, Yurtsever P, Aksoy D, Eskioglu F (1998) Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 134(7):884-885
11. Forstinger C, Kittler H, Binder M (1999) Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream. J Am Acad Dermatol 41(5 Pt 1):775-777
12. Gauwerky K, Klövekorn W, Korting HC et al (2009) Rosacea. J Dtsch Dermatol Ges 7(11):996-1003
13. Gollnick H, Blume-Peytavi U, Szabó EL et al (2010) Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 8(7):505-515
14. Hsu CC, Lee JY (2012) Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective ß-adrenergic blocker. J Am Acad Dermatol 67(3):491-493
15. Jansen T, Plewig G, Kligman AM (1994) Diagnosis and treatment of rosacea fulminans. Dermatology 188(4):251-254
16. Jansen T, Plewig G (1998) Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg 14(4):241-253
17. Karabulut AA, Izol Serel B, Eksioglu HM (2008) A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea. J Eur Acad Dermatol Venereol 22(6):729-734
18. Kim JH, Oh YS, Choi EH (2011) Oral azithromycin for treatment of intractable rosacea. J Korean Med Sci 26(5):694-696
19. Korting HC, Schöllmann C (2009) Tetracycline actions relevant to rosacea treatment. Skin Pharmacol Physiol 22:287-294
20. Krause MH, Torricelli R, Kündig T et al (1997) Dapson bei granulomatöser Rosazea. Hautarzt 48(4):246-248
21. Kroshinsky D, Glick SA (2006) Pediatric rosacea. Dermatol Ther 19:196-201
22. Labro MT (2004) Macrolide antibiotics: current and future uses. Expert Opin Pharmacother 5(3):541-550
23. Lebrun-Vignes B, Kreft-Jais C, Castot A, Chosidow O (2012) Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. Br J Dermatol 166(6):1333-1341
24. Lehmann P (2005) Rosazea. Klinik, Pathogenese, Therapie. Hautarzt 56:871-885
25. Park H, Del Rosso JQ (2011) Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol 4(9):54-61
26. Pfeffer I, Borelli C, Zierhut M, Schaller M (2011) Treatment of ocular rosacea with 40 mg doxy-cycline in a slow release form. J Dtsch Dermatol Ges 9(11):904-907
27. Plewig G (2005) Akne und Rosazea. In: Braun-Falco O, Plewig G, Wolff H et al (Hrsg) Dermatologie und Venerologie. Springer, Berlin, S 885-909
28. Pye RJ, Burton JL (1976) Treatment of rosacea by metronidazole. Lancet 1(7971):1211-1212
29. Rote Liste, Februar 2012. Rote Liste® Service GmbH, Frankfurt/Main
30. Sapadin AN, Fleischmajer R (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258-265
31. Schaller M, Sander CA, Plewig G (2003) Demodexabscesses: clinical and therapeutic challenges. J Am Acad Dermatol 49(5 Suppl):S272-S274
32. Sobottka A, Lehmann P (2009) Rosazea 2009. Neue Erkenntnisse zur Pathophysiologie, klinische Manifestationsformen und Therapiestrategien. Hautarzt 60:999-1009